Financing ·
STERIS signs $1.6B revolving credit and up to $500M delayed draw term loan for Xodus Medical acquisition
STESTERIS plc
On November 4, 2026, STERIS plc entered into a new $1,600 million revolving credit facility maturing in November 2031, replacing its existing agreement. Simultaneously, the company executed a delayed draw term loan agreement providing for up to $500 million, which can only be utilized upon the consummation of the acquisition of Xodus Medical, Inc. The term loan matures five years after the acquisition closing date and includes specific principal repayment schedules during years two through five. No borrowings were incurred on the closing date of the revolving credit agreement. STERIS plc provides medical equipment sterilization and infection prevention products and services.